Turning muscles into motors gives static organs new life
A new biohybrid system developed at MIT is the first living implant that uses rewired nerves to revive paralyzed organs.
MIT engineers design proteins by their motion, not just their shape
An AI model generates novel proteins based on how they vibrate and move, opening new possibilities for dynamic biomaterials and adaptive therapeutics.
Bridging medical realities in the study of technology and health
Anthropologist Amy Moran-Thomas studies overlooked insights from people health care is meant to reach.
After 16 years leading Picower Institute, Li-Huei Tsai will sharpen focus on research, teaching
Tsai, who has grown the MIT neuroscience institute, will increase focus on research including Alzheimer’s disease and Down syndrome.
New sensor sniffs out pneumonia on a patient’s breath
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
Can AI help predict which heart-failure patients will worsen within a year?
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
3 Questions: Building predictive models to characterize tumor progression
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
Fragile X study uncovers brain wave biomarker bridging humans and mice
Researchers find mice modeling the autism spectrum disorder fragile X syndrome exhibit the same pattern of differences in low-frequency waves as humans — a new marker for treatment studies.
Bridging science and society in the emerging bioeconomy
In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.
Using synthetic biology and AI to address global antimicrobial resistance threat
Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
AI algorithm enables tracking of vital white matter pathways
Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
Magnetic mixer improves 3D bioprinting
MagMix, an onboard mixing device, enables scalable manufacturing of 3D-printed tissues.
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.